| Followers | 6717 |
| Posts | 23106 |
| Boards Moderated | 3 |
| Alias Born | 06/27/2006 |
Thursday, October 22, 2020 4:12:40 PM
BRTXQ--What everyone is thinking:
I just wanted to give an update on the elephant in the room in regards to this equity and the undeniable frustration we all share in the time this is taking. There have been numerous times throughout this process that I thought about selling some or most of my shares. Every time I strongly considered this action I reviewed the filings on Pacer, my DD, the DD of others and then would revisit my DD on Auctus and their position. I recognized that frustration is an emotion, just like anger or joy and should not factor into one's investment decisions. As I always state, HOPE is not a valid investment strategy and will leave people who believe otherwise, destitute, of both financial resources and emotion. While we all had hoped everyday, every passing week that the POR would be deemed effective and we could talk about price points and goals, that optimism was met with disappointment. It would be disingenuous of me to state that I too, did not feel that frustration. As previously articulated though, frustration is not an integer of the valid investment strategy, sage investors employ. When viewed in a vacuum, the time it has taken to hammer out this POR, is but a blip in the future success of this enterprise and in the short to intermediate timeframe, a momentary pause in our collective financial gain.
I feel it is imperative to always acknowledge things that have not exactly gone to plan, and always be sincere in the acquiescence of same. People count on thoughts and expressions of opinions on this forum and have learned to adjust their aspersions on those. So I offer this for consideration of the board and all who take the time to read these posts:
What we have here is akin to a marathon race. Everyone that has stayed the course at this point has already run 25.5 miles of the 26.2 mile course. To quit the race now is defeatus in pragmatic logic and common sense. Auctus has underestimated the tenacity of John Desmarais and that has cost them precious time and to some degree, credibility. If you juxtapose that sentiment and apply rationale, the financial boon that awaits all of us, that complete this race, will far exceed these frustrations and disappointments. In other words, in November, people will not be talking about how long it took to get the POR implemented, but rather, how they bought this equity at .005, .01, .02, etc.. and how they stuck it out and what a wonderful holiday season it will be.
So for everyone that needed a shot in the arm or a pep talk, this post is that. Your respective frustration is warranted and admittedly to this point, justified. That being said, STAY THE COURSE. The finish line is around the corner, don't deviate from this race, or you shall regret it. You have come this far, CROSS THE FINISH LINE.
Food for thought.
Most respectfully,
SPORTYNORTY
I just wanted to give an update on the elephant in the room in regards to this equity and the undeniable frustration we all share in the time this is taking. There have been numerous times throughout this process that I thought about selling some or most of my shares. Every time I strongly considered this action I reviewed the filings on Pacer, my DD, the DD of others and then would revisit my DD on Auctus and their position. I recognized that frustration is an emotion, just like anger or joy and should not factor into one's investment decisions. As I always state, HOPE is not a valid investment strategy and will leave people who believe otherwise, destitute, of both financial resources and emotion. While we all had hoped everyday, every passing week that the POR would be deemed effective and we could talk about price points and goals, that optimism was met with disappointment. It would be disingenuous of me to state that I too, did not feel that frustration. As previously articulated though, frustration is not an integer of the valid investment strategy, sage investors employ. When viewed in a vacuum, the time it has taken to hammer out this POR, is but a blip in the future success of this enterprise and in the short to intermediate timeframe, a momentary pause in our collective financial gain.
I feel it is imperative to always acknowledge things that have not exactly gone to plan, and always be sincere in the acquiescence of same. People count on thoughts and expressions of opinions on this forum and have learned to adjust their aspersions on those. So I offer this for consideration of the board and all who take the time to read these posts:
What we have here is akin to a marathon race. Everyone that has stayed the course at this point has already run 25.5 miles of the 26.2 mile course. To quit the race now is defeatus in pragmatic logic and common sense. Auctus has underestimated the tenacity of John Desmarais and that has cost them precious time and to some degree, credibility. If you juxtapose that sentiment and apply rationale, the financial boon that awaits all of us, that complete this race, will far exceed these frustrations and disappointments. In other words, in November, people will not be talking about how long it took to get the POR implemented, but rather, how they bought this equity at .005, .01, .02, etc.. and how they stuck it out and what a wonderful holiday season it will be.
So for everyone that needed a shot in the arm or a pep talk, this post is that. Your respective frustration is warranted and admittedly to this point, justified. That being said, STAY THE COURSE. The finish line is around the corner, don't deviate from this race, or you shall regret it. You have come this far, CROSS THE FINISH LINE.
Food for thought.
Most respectfully,
SPORTYNORTY
Recent BRTX News
- Kaos Capital Announces Acquisition of 4.9% Stake in BioRestorative Therapies (NASDAQ: BRTX) • PR Newswire (US) • 05/27/2026 11:45:00 AM
- Kaos Capital Announces Acquisition of 4.9% Stake in BioRestorative Therapies (NASDAQ: BRTX) • PR Newswire (Canada) • 05/27/2026 11:45:00 AM
- BioRestorative Completes Phase 2 Dosing of BRTX-100, Advancing Lead Regenerative Spine Program Toward 2027 Topline Data • GlobeNewswire Inc. • 05/26/2026 03:00:00 PM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 05/15/2026 07:30:12 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/14/2026 08:31:37 PM
- BioRestorative Therapies Presents New Preclinical Data at ISCT 2026 Highlighting Source-Specific Exosome Functionality and Commercial Applications in BioCosmeceuticals • GlobeNewswire Inc. • 05/13/2026 03:00:00 PM
- BioRestorative Therapies Reports Expanded Phase 2 Blinded Dataset for BRTX-100 Showing Sustained Pain and Functional Improvements in Chronic Lumbar Disc Disease • GlobeNewswire Inc. • 05/07/2026 04:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/01/2026 08:17:58 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 04/30/2026 08:10:19 PM
- BioRestorative Therapies to Present New Data at ISCT 2026 Highlighting Its Ongoing Phase 2 Clinical Trial in Chronic Lumbar Disease and Its BioCosmeceutical Platform • GlobeNewswire Inc. • 04/30/2026 02:36:00 PM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/27/2026 08:05:31 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/23/2026 09:12:57 PM
- BioRestorative Therapies Announces Strategic Partnership with Global Dermatology Leader Dr. David J. Goldberg to Lead Clinical Evaluation and Seek Multi-Channel Adoption of Its Regenerative BioCosmeceutical Platform • GlobeNewswire Inc. • 04/21/2026 12:00:00 PM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/20/2026 09:30:00 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/13/2026 09:22:23 PM
- BioRestorative Therapies Announces Strategic Collaboration with 203 Creates to Build and Commercialize Biocosmeceutical Platform • GlobeNewswire Inc. • 04/07/2026 12:15:00 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 04/03/2026 06:46:20 PM
- BioRestorative Therapies Reports Positive Phase 2 Blinded Data for BRTX-100 Demonstrating Meaningful Improvements in Pain and Function in Chronic Lumbar Disc Disease • GlobeNewswire Inc. • 03/30/2026 12:00:00 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/26/2026 08:20:29 PM
- BioRestorative Therapies to Present Positive Phase 2 Blinded Data for BRTX-100 Demonstrating Meaningful Improvements in Pain and Function in Chronic Lumbar Disc Disease • GlobeNewswire Inc. • 03/19/2026 12:00:00 PM
- BioRestorative Therapies, Inc. to Participate in the Be+Well Beauty and Wellness Show in New York City, March 8-10, 2026 • GlobeNewswire Inc. • 03/05/2026 01:00:00 PM
- BioRestorative Therapies, Inc. Issues Letter to Shareholders Highlighting Major Milestones, Regulatory Alignment, Clinical Execution and Capital Strategy • GlobeNewswire Inc. • 03/04/2026 01:00:00 PM
- BioRestorative secures Australian patent protection for ThermoStem® obesity therapy platform • IH Market News • 02/24/2026 03:14:07 PM
- BioRestorative Expands Global Protection for ThermoStem®, a Potentially Longer-Lasting and Safer Cell-Based Alternative to GLP-1 Drugs • GlobeNewswire Inc. • 02/24/2026 01:30:00 PM
